The US Biopreservation Market was valued at $777.3 Million in 2024 and projected to reach to $1234 Million by 2029, representing a compound annual growth rate of 9.7%. The US biopreservation market is positioned for sustained growth through 2029, driven by expanding cell therapy pipelines, regenerative medicine breakthroughs, and increasing organ transplantation demand.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The US biopreservation market reached $777.3 million in 2024, with projections to grow to $1,234 million by 2029, representing a strong 9.7% CAGR driven by advancing cell therapy and regenerative medicine applications.
The US benefits from robust FDA regulatory frameworks and established guidelines for biopreservation technologies, enabling faster market entry and adoption of innovative preservation solutions across clinical and research settings.
Substantial US government and private sector R&D funding in regenerative medicine, CAR-T cell therapies, and organ transplantation is accelerating biopreservation technology development and commercialization.
Increasing adoption of cryopreservation and advanced preservation techniques in US hospitals and research institutions for cell therapies, stem cell banking, and organ transplantation is fueling market expansion.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | BIOPRESERVATION EQUIPMENT (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.8% from 2024 to 2029 |
| Largest Segment | BIOPRESERVATION MEDIA (Product) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 7.1 (2029) |
| Segments Covered | Product, Type, Biospecimen, Application, End User, Transplant Type |
6 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| BIOBANKS | 588.3 | 657.1 | 726.3 | 801.1 | 886.2 | 979.8 | 1085.2 | 1205 | 10.7 |
| GENE BANKS | 314 | 349 | 383 | 420 | 461 | 506 | 557 | 615 | 9.9 |
| HOSPITALS | 255 | 283 | 309 | 339 | 371 | 407 | 447 | 492 | 9.7 |
| OTHER END USERS | 165 | 183 | 199 | 218 | 238 | 261 | 286 | 314 | 9.6 |
| TOTAL | 1322.3 | 1472.1 | 1617.3 | 1778.1 | 1956.2 | 2153.8 | 2375.2 | 2626 | 10.2 |
The US biopreservation market was valued at $777.3 million in 2024 and is expected to grow to $1,234 million by 2029.
The US biopreservation market is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2029.
Key drivers include rising demand for cell and gene therapies, expansion of regenerative medicine applications, increased organ transplantation procedures, and substantial R&D investments by US pharmaceutical and biotechnology companies.
Advanced cryopreservation systems, automated preservation platforms, and liquid nitrogen-based storage solutions are among the leading technologies driving the US market forward.
The US market grows at 9.7% CAGR, slightly below the global average of 9.8%, but represents the largest absolute market value due to the US healthcare sector's advanced infrastructure and high adoption rates.
The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are:
The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.
The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
A breakdown of the primary respondents is provided below:

Note 1: *Others include sales managers, marketing managers, and product managers.
Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.
Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Biopreservation Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report